Translation of "Infusion therapy" in German

Infusion therapy with superoxide dismutase was started as soon as possible after the primary surgical care.

All infusion pumps supplied by pfm medical are part of a comprehensive solution portfolio for infusion therapy.

This type of administration was continued to the end of infusion therapy.

The Bad Homburg-based company is one of the leading suppliers of nutrition and infusion therapy.

After stopping the infusion, symptomatic therapy is indicated.

Fresenius Kabi is the leading company throughout Europe in nutrition and infusion therapy.

For the intravenous administration via the intravenous infusion therapy, the hexadecylphosphocholine is expediently used in physiological common salt solution.

The nSyte family of needle-free swabable connectors is designed for high flow rate applications in infusion therapy.

Thus a desired infusion therapy can be executed in a way known per se with the infusion pump 2 .

Infusion Therapy Gold Plus is cheap, fast and the result will be pleasantly surprised.

The BodyGuard 323 infusion pump is universally used for infusion therapy in both the hospital and home environment.

Infusion therapy, detoxification is carried out.

In infusion therapy, connectors are the connecting devices to syringes, canulas, and infusion lines.

Benlysta infusions should be administered by a qualified healthcare professional trained to give infusion therapy.

Limited data suggest that co-administration of a single dose of Galafold and a standard enzyme replacement therapy infusion results in an increased exposure to agalsidase of up to 5-fold.

Fresenius is a multinational health company active in hospital management and hospital services, clinical nutrition, dialysis instruments and dialysis solutions as well as infusion therapy.

Limited data suggest that co-administration of a single dose of Galafold and a standard enzyme replacement therapy infusion results in increased exposure to agalsidase of approximately 1- to 5-fold.

It was thus possible by means of the thus described infusion therapy to influence the protein metabolism by replacing with glucose the amino acids content which had been mobilized from the protein-containing tissues and utilized for the energy-production of the cell.

This resulted in the disadvantage for the patient that, in spite of the infusion therapy being employed, in addition to the nerve and muscle proteins, the very valuable functional proteins of the blood which are actively taking part in specific functions of the body, for example in the coagulation, the protection against infection and the like, were included in the combustion process.

It has now been found unexpectedly and surprisingly that the protein metabolism can be influenced more advantageously and properly than by the presently used infusion therapy if for the purpose of the parenteral feeding approximately 1,000 calories are replaced only by amino acids and the amino acids are administered with the aid of an amino acid mixture and a specific quantity of kinin without large amounts of additional energy substrates such as glucose or sugar alcohols, considered necessary heretofore, resulting in a fully balanced nitrogen equilibrium.

In a solution suitable for pharmaceutical administration, the product according to the invention is a medicament for the treatment of coagulopathy, and it can be used intravenously, advantageously as an infusion, for the therapy and prophylaxis of hemorrhages caused by deficiencies in Factor IX and/or Factor X.